Vivos Therapeutics Inc. (VVOS)

NASDAQ: VVOS · Real-Time Price · USD

2.70

-0.03 (-1.10%)

At close: May 02, 2025, 11:28 AM

Vivos Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-11.14M	-13.58M	-23.84M	-20.29M	-12.06M	-10.75M	-8.44M
Depreciation & Amortization	581K	621K	669K	733K	717.87K	751.23K	610.67K
Stock-Based Compensation	762K	n/a	2.4M	2.66M	2.17M	1.99M	1.28M
Other Working Capital	-1.66M	1.88M	474K	-507K	70.15K	1.86M	1.15M
Other Non-Cash Items	42K	-1.85M	-518K	-9K	3.92M	83.07K	364.34K
Deferred Income Tax	n/a	n/a	n/a	1.14M	n/a	60.34K	n/a
Change in Working Capital	-2.94M	2.86M	1.71M	28K	-431.07K	2.53M	867.1K
Operating Cash Flow	-12.69M	-11.95M	-19.59M	-15.73M	-5.68M	-5.34M	-5.31M
Capital Expenditures	n/a	-803K	-924K	-2.4M	-120.25K	-175.6K	-1.25M
Cash Acquisitions	n/a	n/a	n/a	-225K	n/a	250K	133.34K
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-568K	n/a	-924K	13K	-120.25K	11.82K	n/a
Investing Cash Flow	-568K	-853K	-924K	-2.61M	-120.25K	86.22K	-1.12M
Debt Repayment	n/a	n/a	n/a	-25K	1.19M	3.73M	-88.24K
Common Stock Repurchased	n/a	n/a	n/a	-1.5M	-2.15M	-350K	-1M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	10.08M	-1.08M	n/a	-2.24M	-245.14K	738.61K	-12.46K
Financial Cash Flow	17.88M	10.92M	n/a	24.17M	23.54M	4.47M	5.25M
Net Cash Flow	4.62M	-1.88M	-20.51M	5.82M	17.74M	-785.37K	-1.18M
Free Cash Flow	-13.26M	-12.75M	-20.51M	-18.13M	-5.8M	-5.52M	-6.56M